{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:15:05Z","timestamp":1793661305772,"version":"4.5.1"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"abstract":"Context<\/jats:title>Measurements of plasma methoxytyramine, the O-methylated dopamine metabolite, are useful for detecting rare dopamine-producing pheochromocytomas and paragangliomas (PPGLs) and head and neck paragangliomas (HNPGLs), but utility for screening beyond that achieved using standard measurements of normetanephrine and metanephrine is unclear.<\/jats:p><\/jats:sec>Objective<\/jats:title>Evaluation of the additional utility of methoxytyramine compared to plasma normetanephrine and metanephrine for diagnosis of PPGLs and HNPGLs.<\/jats:p><\/jats:sec>Design<\/jats:title>Comparative prospective study.<\/jats:p><\/jats:sec>Methods<\/jats:title>Comparison of mass spectrometric-based measurements of plasma methoxytyramine, normetanephrine and metanephrine in 1963 patients tested for PPGLs at six tertiary medical centers according to reference intervals verified in 423 normotensive and hypertensive volunteers.<\/jats:p><\/jats:sec>Results<\/jats:title>Of the screened patients, 213 had PPGLs and 38 HNPGLs. Using an upper cut-off of 0.10\u2009nmol\/L for methoxytyramine, 0.45\u2009nmol\/L for metanephrine and age-specific upper cut-offs for normetanephrine, diagnostic sensitivity with the addition of methoxytyramine increased from 97.2% to 98.6% for patients with PPGLs and from 22.1% to 50.0% for patients with HNPGLs, with a small decrease in specificity from 95.9% to 95.1%. Addition of methoxytyramine did not significantly alter areas under receiver operating characteristic curves for patients with PPGLs (0.984 vs 0.991), but did increase (P<\/jats:italic>\u2009<\u20090.05) areas for patients with HNPGLs (0.627 vs 0.801). Addition of methoxytyramine also increased the proportion of patients with PPGLs who showed highly positive predictive elevations of multiple metabolites (70.9% vs 49.3%).<\/jats:p><\/jats:sec>Conclusions<\/jats:title>While the benefit of additional measurements of plasma methoxytyramine for the detection of PPGLs is modest, the measurements do assist with positive confirmation of disease and are useful for the detection of HNPGLs.<\/jats:p><\/jats:sec>","DOI":"10.1530\/eje-17-0077","type":"journal-article","created":{"date-parts":[[2017,5,6]],"date-time":"2017-05-06T00:35:10Z","timestamp":1494030910000},"page":"103-113","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":101,"title":["Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma"],"prefix":"10.1093","volume":"177","author":[{"given":"Dipti","family":"Rao","sequence":"first","affiliation":[{"name":"1Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Peitzsch","sequence":"additional","affiliation":[{"name":"2Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Prejbisz","sequence":"additional","affiliation":[{"name":"3Department of Hypertension, Institute of Cardiology, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Hanus","sequence":"additional","affiliation":[{"name":"3Department of Hypertension, Institute of Cardiology, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[{"name":"4Department of Endocrinology, University Hospital W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[{"name":"5Department of Endocrinology, University Hospital M\u00fcnchen, M\u00fcnchen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Brugger","sequence":"additional","affiliation":[{"name":"5Department of Endocrinology, University Hospital M\u00fcnchen, M\u00fcnchen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Fliedner","sequence":"additional","affiliation":[{"name":"6First Department of Medicine, University Medical Center Schleswig-Holstein, L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Langton","sequence":"additional","affiliation":[{"name":"7Departments of Medicine III"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Pamporaki","sequence":"additional","affiliation":[{"name":"7Departments of Medicine III"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Gudziol","sequence":"additional","affiliation":[{"name":"8Departments of Otorhinolaryngology, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Stell","sequence":"additional","affiliation":[{"name":"9Melboune eResearch Group, University of Melbourne, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Januszewicz","sequence":"additional","affiliation":[{"name":"3Department of Hypertension, Institute of Cardiology, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri J L M","family":"Timmers","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques W M","family":"Lenders","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands"},{"name":"7Departments of Medicine III"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Eisenhofer","sequence":"additional","affiliation":[{"name":"2Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden, Germany"},{"name":"7Departments of Medicine III"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"ref151","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1258\/acb.2012.012112","article-title":"Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma","volume":"50","year":"2013","journal-title":"Annals of Clinical Biochemistry"},{"key":"ref561","first-page":"1427","article-title":"Biochemical diagnosis of pheochromocytoma: which test is best?","volume":"287","year":"2002","journal-title":"Journal of the American Medical Association"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1373\/clinchem.2014.224832","article-title":"Laboratory evaluation of pheochromocytoma and paraganglioma","volume":"60","year":"2014","journal-title":"Clinical Chemistry"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1258\/acb.2009.009153","article-title":"Pilot quality assurance programme for plasma metanephrines","volume":"47","year":"2010","journal-title":"Annals of Clinical Biochemistry"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1291\/hypres.27.193","article-title":"Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan","volume":"27","year":"2004","journal-title":"Hypertension Research"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1530\/EJE-13-0529","article-title":"Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites","volume":"169","year":"2013","journal-title":"European Journal of Endocrinology"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1507\/endocrj.EJ14-0384","article-title":"Diagnostic accuracy of plasma free metanephrines in a seated position compared with 24-hour urinary metanephrines in the investigation of pheochromocytoma.","volume":"62","year":"2015","journal-title":"Endocrine Journal"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1373\/clinchem.2014.224832","article-title":"Laboratory evaluation of pheochromocytoma and paraganglioma","volume":"60","year":"2014","journal-title":"Clinical Chemistry"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMcp065470","article-title":"Clinical practice. The incidentally discovered adrenal mass","volume":"356","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1023\/A:1011572617314","article-title":"Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma","volume":"2","year":"2001","journal-title":"Reviews in Endocrine and Metabolic Disorders"},{"key":"ref511","first-page":"637","article-title":"survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian Society of Endocrinology","volume":"85","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/HJH.0b013e32813aeb5a","article-title":"Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients","volume":"25","year":"2007","journal-title":"Journal of Hypertension"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1258\/acb.2012.012066","article-title":"Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma","volume":"50","year":"2013","journal-title":"Annals of Clinical Biochemistry"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1210\/jc.2004-2025","article-title":"Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine","volume":"90","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1291\/hypres.27.193","article-title":"Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan","volume":"27","year":"2004","journal-title":"Hypertension Research"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1023\/A:1011572617314","article-title":"Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma","volume":"2","year":"2001","journal-title":"Reviews in Endocrine and Metabolic Disorders"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1373\/clinchem.2015.239962","article-title":"Interference from 3-O-methyldopa with ultra-high performance LC-MS\/MS measurements of plasma metanephrines: chromatographic separation remains important","volume":"61","year":"2015","journal-title":"Clinical Chemistry"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","year":"2005","journal-title":"Lancet"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.cca.2010.01.012","article-title":"Performance of plasma free metanephrines measured by liquid chromatography-tandem mass spectrometry in the diagnosis of pheochromocytoma","volume":"411","year":"2010","journal-title":"Clinica Chimica Acta"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1507\/endocrj.EJ14-0384","article-title":"Diagnostic accuracy of plasma free metanephrines in a seated position compared with 24-hour urinary metanephrines in the investigation of pheochromocytoma.","volume":"62","year":"2015","journal-title":"Endocrine Journal"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1210\/jc.2009-0303","article-title":"Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors","volume":"94","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.ejca.2011.07.016","article-title":"Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status","volume":"48","year":"2012","journal-title":"European Journal of Cancer"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.cca.2010.01.012","article-title":"Performance of plasma free metanephrines measured by liquid chromatography-tandem mass spectrometry in the diagnosis of pheochromocytoma","volume":"411","year":"2010","journal-title":"Clinica Chimica Acta"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1373\/clinchem.2015.239962","article-title":"Interference from 3-O-methyldopa with ultra-high performance LC-MS\/MS measurements of plasma metanephrines: chromatographic separation remains important","volume":"61","year":"2015","journal-title":"Clinical Chemistry"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2125.1981.tb01210.x","article-title":"Renal conversion of plasma DOPA to urine dopamine","volume":"12","year":"1981","journal-title":"British Journal of Clinical Pharmacology"},{"key":"ref111","first-page":"577","article-title":"False positive test results for pheochromocytoma from 2000 to 2008","volume":"118","year":"2010","journal-title":"Experimental and Clinical Endocrinology and Diabetes"},{"key":"ref401","first-page":"577","article-title":"False positive test results for pheochromocytoma from 2000 to 2008","volume":"118","year":"2010","journal-title":"Experimental and Clinical Endocrinology and Diabetes"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/HJH.0b013e32813aeb5a","article-title":"Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients","volume":"25","year":"2007","journal-title":"Journal of Hypertension"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1210\/jc.2009-0303","article-title":"Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors","volume":"94","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1258\/acb.2010.010131","article-title":"An audit of management of patients with borderline increased plasma-free metanephrines","volume":"47","year":"2010","journal-title":"Annals of Clinical Biochemistry"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1373\/clinchem.2010.153320","article-title":"Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma","volume":"57","year":"2011","journal-title":"Clinical Chemistry"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6823-4-2","article-title":"A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma","volume":"4","year":"2004","journal-title":"BMC Endocrine Disorders"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2125.1981.tb01210.x","article-title":"Renal conversion of plasma DOPA to urine dopamine","volume":"12","year":"1981","journal-title":"British Journal of Clinical Pharmacology"},{"key":"ref271","first-page":"1427","article-title":"Biochemical diagnosis of pheochromocytoma: which test is best?","volume":"287","year":"2002","journal-title":"Journal of the American Medical Association"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1258\/acb.2010.010131","article-title":"An audit of management of patients with borderline increased plasma-free metanephrines","volume":"47","year":"2010","journal-title":"Annals of Clinical Biochemistry"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an Endocrine Society Clinical Practice Guideline","volume":"99","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1530\/EJE-13-0529","article-title":"Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites","volume":"169","year":"2013","journal-title":"European Journal of Endocrinology"},{"key":"ref221","first-page":"637","article-title":"survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian Society of Endocrinology","volume":"85","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","year":"2005","journal-title":"Lancet"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0009-9120(00)00172-7","article-title":"A five-year report on experience in the detection of pheochromocytoma.","volume":"33","year":"2000","journal-title":"Clinical Biochemistry"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.ejca.2011.07.016","article-title":"Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status","volume":"48","year":"2012","journal-title":"European Journal of Cancer"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1258\/acb.2009.009153","article-title":"Pilot quality assurance programme for plasma metanephrines","volume":"47","year":"2010","journal-title":"Annals of Clinical Biochemistry"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1373\/clinchem.2006.070805","article-title":"Measurement of urinary metanephrines to screen for pheochromocytoma in an unselected hospital referral population","volume":"52","year":"2006","journal-title":"Clinical Chemistry"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/cen.12327","article-title":"Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions","volume":"80","year":"2014","journal-title":"Clinical Endocrinology"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.5858\/2008-132-1272-PAEPU","article-title":"Pheochromocytoma and extra-adrenal paraganglioma: updates","volume":"132","year":"2008","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1258\/acb.2012.012066","article-title":"Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma","volume":"50","year":"2013","journal-title":"Annals of Clinical Biochemistry"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1373\/clinchem.2010.153320","article-title":"Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma","volume":"57","year":"2011","journal-title":"Clinical Chemistry"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6823-4-2","article-title":"A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma","volume":"4","year":"2004","journal-title":"BMC Endocrine Disorders"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1373\/clinchem.2006.070805","article-title":"Measurement of urinary metanephrines to screen for pheochromocytoma in an unselected hospital referral population","volume":"52","year":"2006","journal-title":"Clinical Chemistry"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2008-1093","article-title":"Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene","volume":"93","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1210\/jc.2004-2025","article-title":"Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine","volume":"90","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2008-1093","article-title":"Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene","volume":"93","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/cen.12327","article-title":"Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions","volume":"80","year":"2014","journal-title":"Clinical Endocrinology"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1258\/acb.2012.012112","article-title":"Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma","volume":"50","year":"2013","journal-title":"Annals of Clinical Biochemistry"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0009-9120(00)00172-7","article-title":"A five-year report on experience in the detection of pheochromocytoma.","volume":"33","year":"2000","journal-title":"Clinical Biochemistry"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an Endocrine Society Clinical Practice Guideline","volume":"99","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMcp065470","article-title":"Clinical practice. The incidentally discovered adrenal mass","volume":"356","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.5858\/2008-132-1272-PAEPU","article-title":"Pheochromocytoma and extra-adrenal paraganglioma: updates","volume":"132","year":"2008","journal-title":"Archives of Pathology and Laboratory Medicine"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/177\/2\/EJE-17-0077.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1530\/EJE-17-0077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T16:10:36Z","timestamp":1676391036000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/177\/2\/103\/6655297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":58,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1530\/eje-17-0077","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}